Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

TRLVBullishEarningsShort Term

High materiality9/10

Trulieve Reports Second Quarter 2026 Results

StockNews.AIAug 7, 6:15 AM EDT1 source

Trading thesisImportance 9/10

Bullish near-term: TRLV likely to rise in 4–8 weeks on NYSE listing and solid cash generation; longer-term upside hinges on regulatory progress andSTATE program expansions.

AI summary

What happened and why it matters

Trulieve reported Q2 2026 revenue of $271 million with a 60% gross margin and $98 million in adjusted EBITDA (36% of revenue). GAAP net loss was $406 million due largely to Harvest deconsolidation, though adjusted net income was $20 million. The company secured an NYSE listing (ticker TRLV), announced a $50 million share repurchase, and expanded Georgia and Florida operations, supporting near-term upside despite one-off GAAP hits.

NYSAE listing of TRLV provides potential multiple expansion and better liquidity.
Harvest deconsolidation creates one-off GAAP headwinds but cleaner long-term cash flow.
Share repurchase up to $50 million reduces float and can lift EPS.
Georgia and Texas program expansions may unlock incremental growth in H2 2026.

Sentiment rationale

The NYSE listing elevates branding, liquidity, and market access. Non-GAAP metrics show meaningful profitability leverage (adjusted EBITDA 36% of revenue) despite GAAP losses from Harvest. A $50m buyback and Georgia/Florida expansion are near-term catalysts, while the Harvest deconsolidation, though depressing GAAP results, reduces future overhang and improves cash-flow visibility. Historically, such mix of cash-flow strength plus capital-market catalysts tends to support a short- to mid-term re-rating in small-cap cannabis names.

Key facts

01
Q2 2026 revenue was $271 million with 60% gross margin.
02
Harvest deconsolidation completed June 3, 2026; GAAP loss inflated by $407m.
03
Trulieve listed on NYSE under TRLV; share repurchase up to $50m.
04
Adjusted EBITDA $98m (36% of revenue); adjusted net income $20m.
05
Georgia expansion and Florida store openings; 207 retail dispensaries, 3.5m sq ft capacity.

Earnings

Category: Earnings and Corporate Developments. The release blends quarterly earnings with strategic corporate actions (domestication to Delaware, Harvest deconsolidation, share repurchase, NYSE listing) that alter the timeline and optics of Trulieve's growth trajectory.